Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases [NA]
Clinical trial update indicates completion of a study evaluating intensity-modulated radiation therapy in younger patients with lung metasta…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Role of the Vascular Surgeon in Orthopedic Surgery of Musculoskeletal Tumors
A clinical trial update indicates that NCT06818552, sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna, is examining the role o…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas [Phase 2]
Phase 2 trial evaluating preoperative radiotherapy with liposomal transcrocetin (L-TC) for soft tissue sarcoma; the study is not yet recruit…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY) [NA]
This document describes a randomized study evaluating early involvement of palliative care alongside standard treatment versus standard trea…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sarcoma Patients [NA]
Completed clinical trial evaluating safety and efficacy of combined microwave ablation during limb-sparing surgery for high-risk soft tissue…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma [Phase 2]
Phase 2 trial update reporting efficacy and safety results for L19TNF in previously treated patients with advanced or metastatic Soft tissue…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Project HERO: Health Empowerment & Recovery Outcomes [NA]
Rutgers, The State University of New Jersey's Project HERO trial has completed, reporting health empowerment and recovery outcomes across m…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Hypofractionated Radiotherapy for Soft Tissue Sarcomas [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiotherapy for soft tissue sarcoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
This entry reports on a clinical trial (NCT06774729) sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna evaluating a radiomics …
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS [Phase 1, Phase 2]
This Clinical Trials update describes a Phase 1/Phase 2 trial evaluating intratumoral injection of IP-001 following thermal ablation in pati…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities [NA]
This document reports a clinical trial assessing the safety and efficacy of preoperative stereotactic body radiotherapy followed by radical …
-
FDA label_change · 2025-01-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for doxorubicin hydrochloride from Zydus Lifesciences Limited, updating the labeling for the product…
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]
This is a Phase 1 study to evaluate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal junc…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating VG161 for advanced bone and soft tissue sarcoma and is currently recruiting; sponsor CNBG-Virogin Bio…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: 89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma [Phase 1]
This Phase 1 study evaluates the dosimetry of 89Zr-olaratumab in participants with soft tissue sarcoma. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma [Phase 2]
Completed Phase 2 clinical trial evaluating pemetrexed plus cisplatin in patients with refractory soft tissue sarcoma.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Pemetrexed, Cisplatin With Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating pemetrexed in combination with cisplatin for soft tissue sarcoma and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors [Phase 1]
A Phase 1 study evaluating the safety and tolerability of CFT8634 in SMARCB1-perturbed cancers, including Synovial Sarcoma and SMARCB1-null …
-
CLINICAL_TRIALS approval · 2024-12-16Clinical Trial Update: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Olaratumab has been approved for marketing for soft tissue sarcoma.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
A clinical trial evaluating 68Ga-grazytracer PET for monitoring responses to immunotherapy in advanced soft tissue sarcoma is currently recr…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy [NA]
A University Medical Center Groningen clinical trial is evaluating quantitative margin assessment using high-resolution PET-CT in oral squam…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas [NA]
A completed clinical trial update examining PSMA expression and PSMA PET imaging in soft tissue sarcomas and urothelial carcinoma.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas [NA]
This clinical trial update outlines a study investigating immunological examinations through blood and tissue extraction during neoadjuvant …
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. [Phase 2]
A Phase 2 randomized trial in advanced, metastatic, or unresectable soft tissue sarcoma that progressed after standard treatments has comple…